LONDON, United Kingdom: Syncona Limited, a leading healthcare company focused on creating, building and scaling a portfolio of global leaders in life science, announced that its newly established portfolio company has successfully completed its previously announced acquisition of Applied Genetic Technologies Corporation (“AGTC”) (Nasdaq: AGTC), a clinical-stage biotechnology company focused on the development and commercialisation…